Kozak & Associates
ABBV icon

Kozak & Associates’s AbbVie ABBV Stock Holding History

Kozak & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$508K Sell
1,777
-2,989
-63% -$766K 0.09% 44
2026
Q2 		$1.2M Buy
4,766
+11
+0.2% +$2.37K 0.21% 29
2026
Q1 		$982K Sell
4,755
-215
-4% -$47.7K 0.19% 26
2025
Q4 		$1.09M Buy
4,970
+96
+2% +$21.9K 0.21% 25
2025
Q3 		$1.14M Buy
4,874
+25
+0.5% +$5.09K 0.22% 26
2025
Q2 		$924K Buy
4,849
+3,015
+164% +$560K 0.19% 26
2025
Q1 		$328K Buy
1,834
+113
+7% +$22K 0.08% 52
2024
Q4 		$312K Buy
1,721
+39
+2% +$7.17K 0.07% 55
2024
Q3 		$320K Buy
1,682
+211
+14% +$39.4K 0.08% 60
2024
Q2 		$241K Hold
1,471
– – 0.06% 70
2024
Q1 		$242K Sell
1,471
-42
-3% -$7.24K 0.07% 72
2023
Q4 		$244K Sell
1,513
-186
-11% -$27.1K 0.08% 69
2023
Q3 		$252K Buy
1,699
+10
+0.6% +$1.47K 0.09% 70
2023
Q2 		$228K Sell
1,689
-63
-4% -$9.24K 0.09% 77
2023
Q1 		$279K Buy
1,752
+11
+0.6% +$1.68K 0.13% 74
2022
Q4 		$281K Buy
1,741
+10
+0.6% +$1.53K 0.14% 67
2022
Q3 		$245K Buy
1,731
+11
+0.6% +$1.58K 0.15% 67
2022
Q2 		$263K Buy
1,720
+10
+0.6% +$1.53K 0.18% 58
2022
Q1 		$255K Hold
1,710
– – 0.16% 65
2021
Q4 		$255K Buy
1,710
+23
+1% +$2.72K 0.16% 65
2021
Q3 		$197K Buy
+1,687
New +$193K 0.12% 79

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Kozak & Associates's ABBV Position: Q3 2026 in Review

Kozak & Associates reduced its AbbVie (ABBV) stake by 63% in Q3 2026, selling an estimated $766K and leaving 1,777 shares worth $508K. The position accounts for 0.09% of the portfolio, ranked #44.

Kozak & Associates first reported a position in ABBV in Q3 2021 and has held it in 21 quarters since. The position peaked at $1.2M in Q2 2026. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Kozak & Associates held 1,777 shares of AbbVie worth $508K as of Q3 2026.
  • Kozak & Associates sold 2,989 AbbVie shares in Q3 2026, an estimated $766K.
  • AbbVie made up 0.09% of Kozak & Associates's portfolio in Q3 2026, its #44 holding.
  • Kozak & Associates first reported a position in AbbVie in Q3 2021 and has held it in 21 quarters since.
  • Kozak & Associates's AbbVie position peaked at $1.2M in Q2 2026.
  • 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Kozak & Associates's 13F filing for Q3 2026, filed 29 Oct 2026.